In this article we are going to delve into the fascinating world of ROD-188, exploring its multiple dimensions and facets. From its origins to its relevance today, we will dive into an exhaustive analysis that will allow us to understand the importance of ROD-188 in various areas of life. Through diverse perspectives and interdisciplinary approaches, we will examine its impact on society, culture, history and technology, offering a comprehensive view that will enrich our knowledge of ROD-188. This article will provide a panoramic view that will invite us to reflect on the relevance and value of ROD-188 in our current world.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C20H21NO4S |
Molar mass | 371.45 g·mol−1 |
3D model (JSmol) | |
| |
(verify) |
ROD-188 is a sedative drug that was structurally derived from the GABAA antagonist bicuculline by a team at Roche. Unlike bicuculline, ROD-188 acts as an agonist at GABAA receptors, being a positive allosteric modulator acting at a novel binding site distinct from those of benzodiazepines, barbiturates or muscimol, with its strongest effect produced at the α6β2γ2 subtype of the GABAA receptor. ROD-188 is one of a number of related compounds acting at this novel modulatory site, some of which also act at benzodiazepine receptors.